PHS
EYPT icon

PFM Health Sciences’s EyePoint Inc EYPT Stock Holding History

PFM Health Sciences’s Portfolio EYPT Stock Details EYPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-292,926
Closed -$2.55M – 79
2024
Q2 		$2.55M Buy
292,926
+122,055
+71% +$1.7M 0.13% 65
2024
Q1 		$3.53M Hold
170,871
– – 0.17% 75
2023
Q4 		$3.95M Buy
+170,871
New +$1.91M 0.24% 55

Other funds holding EYPT

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

PFM Health Sciences's EYPT Position: Q3 2024 in Review

PFM Health Sciences sold out of EyePoint Inc (EYPT) in Q3 2024, closing a stake of 292,926 shares — an estimated $2.55M sold.

PFM Health Sciences first reported a position in EYPT in Q4 2023 and held it in 3 quarters. The position peaked at $3.95M in Q4 2023. 138 funds tracked by Wall St. Rank hold EYPT as of Q3 2024.

  • PFM Health Sciences reported no remaining EyePoint Inc position as of Q3 2024 after selling out during the quarter.
  • PFM Health Sciences sold 292,926 EyePoint Inc shares in Q3 2024, an estimated $2.55M.
  • PFM Health Sciences first reported a position in EyePoint Inc in Q4 2023 and held it in 3 quarters.
  • PFM Health Sciences's EyePoint Inc position peaked at $3.95M in Q4 2023.
  • 138 funds tracked by Wall St. Rank held EyePoint Inc as of Q3 2024.

Based on PFM Health Sciences's 13F filing for Q3 2024, filed 14 Nov 2024.